Neurodegenerative diseases like Alzheimer's and Parkinson's are some of the most difficult puzzles in medicine because they involve proteins that "misfold" and clump together in the brain. Standard treatments have struggled to stop this process, but the Unnatural Amino Acids (UAAs) Sector is offering a new strategy: "molecular crowbars." By designing small peptides that contain specific...